DexCom ROE 2010-2025 | DXCM
Current and historical return on equity (ROE) values for DexCom (DXCM) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| DexCom ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $0.54B | $2.27B | 24.41% |
| 2024-12-31 | $0.58B | $2.10B | 26.34% |
| 2024-09-30 | $0.68B | $1.98B | 31.21% |
| 2024-06-30 | $0.67B | $2.43B | 29.59% |
| 2024-03-31 | $0.64B | $2.25B | 29.43% |
| 2023-12-31 | $0.54B | $2.07B | 25.01% |
| 2023-09-30 | $0.38B | $2.27B | 17.31% |
| 2023-06-30 | $0.36B | $2.10B | 17.27% |
| 2023-03-31 | $0.29B | $2.23B | 13.88% |
| 2022-12-31 | $0.34B | $2.13B | 16.23% |
| 2022-09-30 | $0.24B | $1.83B | 11.74% |
| 2022-06-30 | $0.23B | $2.26B | 10.67% |
| 2022-03-31 | $0.26B | $2.19B | 12.29% |
| 2021-12-31 | $0.22B | $2.04B | 10.74% |
| 2021-09-30 | $0.63B | $2.14B | 32.20% |
| 2021-06-30 | $0.62B | $2.00B | 34.21% |
| 2021-03-31 | $0.59B | $1.90B | 35.61% |
| 2020-12-31 | $0.55B | $1.83B | 39.11% |
| 2020-09-30 | $0.23B | $1.50B | 19.78% |
| 2020-06-30 | $0.21B | $1.35B | 20.83% |
| 2020-03-31 | $0.15B | $0.94B | 18.10% |
| 2019-12-31 | $0.10B | $0.88B | 13.45% |
| 2019-09-30 | $-0.17B | $0.76B | -24.71% |
| 2019-06-30 | $-0.17B | $0.69B | -26.49% |
| 2019-03-31 | $-0.13B | $0.67B | -21.89% |
| 2018-12-31 | $-0.13B | $0.66B | -23.86% |
| 2018-09-30 | $0.04B | $0.56B | 9.34% |
| 2018-06-30 | $-0.01B | $0.48B | -1.17% |
| 2018-03-31 | $-0.03B | $0.42B | -8.11% |
| 2017-12-31 | $-0.05B | $0.42B | -13.94% |
| 2017-09-30 | $-0.05B | $0.38B | -14.77% |
| 2017-06-30 | $-0.07B | $0.35B | -22.07% |
| 2017-03-31 | $-0.09B | $0.28B | -32.90% |
| 2016-12-31 | $-0.07B | $0.28B | -25.42% |
| 2016-09-30 | $-0.06B | $0.26B | -23.33% |
| 2016-06-30 | $-0.08B | $0.25B | -35.91% |
| 2016-03-31 | $-0.06B | $0.23B | -31.37% |
| 2015-12-31 | $-0.06B | $0.22B | -31.61% |
| 2015-09-30 | $-0.06B | $0.19B | -36.14% |
| 2015-06-30 | $-0.02B | $0.17B | -14.61% |
| 2015-03-31 | $-0.02B | $0.15B | -18.25% |
| 2014-12-31 | $-0.02B | $0.14B | -20.67% |
| 2014-09-30 | $-0.03B | $0.12B | -27.76% |
| 2014-06-30 | $-0.03B | $0.10B | -32.09% |
| 2014-03-31 | $-0.03B | $0.09B | -39.88% |
| 2013-12-31 | $-0.03B | $0.08B | -39.34% |
| 2013-09-30 | $-0.04B | $0.08B | -46.98% |
| 2013-06-30 | $-0.05B | $0.07B | -60.73% |
| 2013-03-31 | $-0.05B | $0.07B | -63.35% |
| 2012-12-31 | $-0.05B | $0.08B | -62.07% |
| 2012-09-30 | $-0.06B | $0.08B | -61.70% |
| 2012-06-30 | $-0.05B | $0.09B | -52.81% |
| 2012-03-31 | $-0.05B | $0.10B | -41.82% |
| 2011-12-31 | $-0.04B | $0.11B | -44.78% |
| 2011-09-30 | $-0.04B | $0.11B | -48.14% |
| 2011-06-30 | $-0.04B | $0.12B | -61.99% |
| 2011-03-31 | $-0.05B | $0.05B | -98.95% |
| 2010-12-31 | $-0.06B | $0.06B | -119.57% |
| 2010-09-30 | $-0.06B | $0.04B | -217.14% |
| 2010-06-30 | $-0.06B | $0.04B | -380.33% |
| 2010-03-31 | $-0.06B | $0.05B | -1109.09% |
| 2009-12-31 | $-0.05B | $-0.02B | 2160.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $33.596B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $188.582B | 82.60 |
| Thermo Fisher Scientific (TMO) | United States | $154.218B | 18.65 |
| Edwards Lifesciences (EW) | United States | $44.793B | 29.37 |
| Alcon (ALC) | Switzerland | $43.149B | 29.16 |
| IDEXX Laboratories (IDXX) | United States | $41.707B | 47.93 |
| IQVIA Holdings (IQV) | United States | $26.668B | 14.94 |
| Mettler-Toledo (MTD) | United States | $24.844B | 29.55 |
| STERIS (STE) | Ireland | $23.875B | 26.30 |
| Waters (WAT) | United States | $20.729B | 29.25 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.648B | 0.00 |
| Hologic (HOLX) | United States | $14.389B | 15.63 |
| Sysmex ADR (SSMXY) | Japan | $10.323B | 29.29 |
| Penumbra (PEN) | United States | $9.933B | 77.96 |
| Masimo (MASI) | United States | $9.319B | 34.38 |
| Globus Medical (GMED) | United States | $8.169B | 19.47 |
| Teleflex (TFX) | United States | $5.447B | 8.99 |
| Glaukos (GKOS) | United States | $5.408B | 0.00 |
| TransMedics (TMDX) | United States | $4.715B | 102.50 |
| Integer Holdings (ITGR) | United States | $4.259B | 22.31 |
| PROCEPT BioRobotics (PRCT) | United States | $3.478B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.525B | 15.03 |
| Nihon Kohden (NHNKY) | Japan | $2.253B | 25.84 |
| Veracyte (VCYT) | United States | $2.181B | 30.60 |
| Elekta AB (EKTAY) | Sweden | $2.013B | 18.10 |
| Alphatec Holdings (ATEC) | United States | $1.742B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.246B | 116.76 |
| Pulse Biosciences (PLSE) | United States | $1.163B | 0.00 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.079B | 5.74 |
| Beta Bionics (BBNX) | United States | $0.842B | 0.00 |
| SiBone (SIBN) | United States | $0.804B | 0.00 |
| IRadimed (IRMD) | United States | $0.773B | 39.23 |
| RxSight (RXST) | United States | $0.622B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.09 |
| Mesa Laboratories (MLAB) | United States | $0.561B | 13.15 |
| Delcath Systems (DCTH) | United States | $0.555B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.523B | 0.00 |
| AxoGen (AXGN) | United States | $0.474B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| NeuroPace (NPCE) | United States | $0.424B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.379B | 10.09 |
| ClearPoint Neuro (CLPT) | United States | $0.373B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.371B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
| 908 Devices (MASS) | United States | $0.250B | 0.00 |
| Neuronetics (STIM) | United States | $0.245B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.238B | 14.41 |
| Alpha Tau Medical (DRTS) | Israel | $0.220B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.210B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.172B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.172B | 0.00 |
| CVRx (CVRX) | United States | $0.162B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.141B | 0.00 |
| Accuray (ARAY) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.118B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 50.00 |
| EnVVeno Medical (NVNO) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.031B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.36 |